logo
logo

Trefoil Therapeutics, Inc. announced it raised $4.16 Million in an initial filing from an offering of $5.16 Million

Dec 08, 2016over 8 years ago

Amount Raised

$4.16 Million

El CajonBiotechnology

Company Information

Company

Trefoil Therapeutics

Location

14417 Ranch Trail Drive

El Cajon, California, United States

About

Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies. Founded and led by scientists with deep experience in the ophthalmology field, Trefoil is advancing an approach that leverages novel technology to treat a number of different corneal diseases. The company’s lead investigational medicine – TTHX1114 – has the potential to be first-in-class and is being studied for the treatment of corneal endothelial dystrophies and conditions via intracameral injection.

FundzWatch™ Score

76
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People